{
  "trial_id": "NCT04694586",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient 18 years and older",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Confirmed pulmonary TB (positive Mtb culture or positive polymerase chain reaction (PCR) Mtb-complex)",
      "label": "met",
      "evidence": "sputum smear revealed positive sputum culture for Mycobacterium tuberculosis"
    },
    {
      "criterion": "Intended to start on first-line TB treatment",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "HIV negative",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "BMI >17",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Written Informed Consent",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Women of childbearing potential should agree on adequate contraceptives during treatment period and have a negative pregnancy test prior to treatment initiation",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Person who the investigator, after consultation with the central contact persons of the study, finds by other reason than the above listed not suitable for study participation",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Not able to provide informed consent/unable to assimilate study information",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Concomitant infectious disease that requires treatment",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Known allergy to rifamycins, isoniazid, pyrazinamide, ethambutol or history of severe sideeffect to any of the drugs",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Drug-induced inflammatory liver diseases in medical history",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "History of acute liver disease",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "On-going liver disease including hepatitis and elevated transaminase levels >x5 upper normal limit",
      "label": "not_met",
      "evidence": "AST: 13 U/L, ALT: 15 U/L"
    },
    {
      "criterion": "Porphyria",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Drug-drug interaction between concomitant drugs and rifampicin that could not be bridged by dose-adjustment of the concomitant drug",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "46",
    "trial_id": "NCT04694586",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}